American International Group’s Northwest Biotherapeutics, Inc. NWBOW Stock Holding History

American International Group’s Portfolio NWBOW Stock Details NWBOW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-2,640	Closed	-$7K	–	5193
2014 Q4	$7K	Sell	2,640 -860	-25%	-$2.46K	﹤0.01%	4621
2014 Q3	$10.5K	Hold	3,500	–	–	﹤0.01%	4510
2014 Q2	$13.3K	Hold	3,500	–	–	﹤0.01%	4417
2014 Q1	$17K	Sell	3,500 -3,000	-46%	-$11.1K	﹤0.01%	4245
2013 Q4	$18K	Buy	+6,500	New	+$17.4K	﹤0.01%	4162

Other funds holding NWBOW

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

American International Group's NWBOW Position: Q1 2015 in Review

American International Group sold out of Northwest Biotherapeutics, Inc. (NWBOW) in Q1 2015, closing a stake of 2,640 shares — an estimated $7K sold.

American International Group first reported a position in NWBOW in Q4 2013 and held it in 5 quarters. The position peaked at $18K in Q4 2013. 1 fund tracked by Wall St. Rank holds NWBOW as of Q1 2015.

American International Group reported no remaining Northwest Biotherapeutics, Inc. position as of Q1 2015 after selling out during the quarter.
American International Group sold 2,640 Northwest Biotherapeutics, Inc. shares in Q1 2015, an estimated $7K.
American International Group first reported a position in Northwest Biotherapeutics, Inc. in Q4 2013 and held it in 5 quarters.
American International Group's Northwest Biotherapeutics, Inc. position peaked at $18K in Q4 2013.
1 fund tracked by Wall St. Rank held Northwest Biotherapeutics, Inc. as of Q1 2015.

Based on American International Group's 13F filing for Q1 2015, filed 14 May 2015.